Purchase Order 75N94025P00367
Award Date
7/11/25
Potential Completion Date
1/10/26
Potential Value
$27K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for maintenance services on a Sequel II long sequencer, a specialized DNA/RNA sequencing instrument manufactured by Pacific Biosciences of California, Inc. The $18,196.67 firm-fixed price purchase order was awarded on March 11, 2025 by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. Pacific Biosciences is the original equipment manufacturer for the Sequel II system and has...
This is a one-year, firm fixed-price service contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. The $32,500 contract is for the provision of an annual support agreement on the vendor's proprietary Sequel DNA/RNA sequencing equipment and associated services. The contract does not have a set-aside designation. Pacific Biosciences provides specialized...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $53,000 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide PacBio Sequel II sequencing services under a one-year agreement. The contract supports NICHD's research objectives by delivering next-generation DNA and RNA sequencing and analysis capabilities from January 2022 through January 2023. Pacific Biosciences will perform the sequencing services at its...
This is a firm fixed-price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Pacific Biosciences of California, Inc. The contract is for the procurement of a Sequel II sequencing system, associated services, and consumables for the period of August 15, 2024 through August 14, 2025, with a potential completion date of August 14, 2025. The ceiling value of this contract is $65,508.00. This contract was awarded...
This is a firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc. for $35,000.00. The contract is for the provision of Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related support services. The contract was awarded on a sole-source basis, as Pacific Biosciences was determined to be the only responsible source capable of meeting NIAID's...
This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,661 purchase order to Pacific Biosciences of California, Inc. for supplies and reagents to support the Sequel IIE sequencing platform. As a one-year firm fixed price contract set to run from July 2027 through July 2028, Pacific Biosciences will provide NICHD with the consumables needed for its genomic research and analysis efforts. No subcontractors or additional context was indicated....
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Pacific Biosciences of California, Inc. on July 19, 2018 for the provision of a PacBio Sequel DNA sequencer. The potential value of the contract is $337,500.00. Pacific Biosciences is a manufacturer and provider of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA...
This is a firm fixed-price purchase order issued by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment, reagents, and services. The $175,000.00 contract provides a service and maintenance agreement for Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, including software updates and annual preventative maintenance visits. Pacific Biosciences has...
Pacific Biosciences of California, Inc. was awarded a $53,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide a Sequel II instrument service contract with insight from August 15, 2023 through August 14, 2024. The contract will deliver service and support for Pacific Biosciences' Sequel II sequencing systems to assist the agency's genomic research efforts. No set aside designation or subcontractors were identified. The...